The aesthetics injectables market has historically grown by more than 10 percent a year. This rapid growth has attracted corporate money to this market. Expanded access to services (primarily via aesthetics clinic chains, med spas, and beauty bars) and growing consumer purchasing power have accelerated global penetration, especially in emerging markets.Shifting consumer attitudes about wellness, beauty, and healthy aging have increased awareness and acceptance of aesthetics, generating demand from new patient segments, including men and millennials.
This is having a dramatic affect on both consumers and providers. Will corporate dollars control and influence medical decisions. When a provider is purchased by a private equity group or a venture capital group many things happen. Now the provider must meet quotas for number of patients seen, and the amount of money generated. Ultimately, this may have impact on medical decisions. This is the concern of both patients and providers. Providers must also be concerned about being replaced by less expensive employees, and also having less input on their business.
Especially over the last few years, an influx of money has invaded the aesthetic medicine space. This has developed many regional and national med spa chains. Prices of procedures have been going down in these chain Medspa’s. The question begs to be answered I’ll be losing quality of care and best medical decision-making.